These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36992279)

  • 1. The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development.
    Kozak M; Hu J
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of viral vectors in vaccine development.
    Travieso T; Li J; Mahesh S; Mello JDFRE; Blasi M
    NPJ Vaccines; 2022 Jul; 7(1):75. PubMed ID: 35787629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The next generation of HCV vaccines: a focus on novel adjuvant development.
    Kardani K; Sadat SM; Kardani M; Bolhassani A
    Expert Rev Vaccines; 2021 Jul; 20(7):839-855. PubMed ID: 34114513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal and sublingual delivery of inactivated polio vaccine.
    Kraan H; Soema P; Amorij JP; Kersten G
    Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.
    Reinke S; Thakur A; Gartlan C; Bezbradica JS; Milicic A
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32971761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of live vaccines by co-delivery of immune modulating proteins.
    Manohar MM; Campbell BE; Walduck AK; Moore RJ
    Vaccine; 2022 Sep; 40(40):5769-5780. PubMed ID: 36064671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.
    Wilson-Welder JH; Boggiatto P; Nally JE; Wafa EI; Alt DP; Hornsby RL; Frank A; Jones DE; Olsen SC; Bowden NB; Salem AK
    Vaccine; 2020 Apr; 38(18):3464-3473. PubMed ID: 32204939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentials of saponins-based adjuvants for nasal vaccines.
    Chen K; Wang N; Zhang X; Wang M; Liu Y; Shi Y
    Front Immunol; 2023; 14():1153042. PubMed ID: 37020548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness.
    Pogostin BH; McHugh KJ
    Bioengineering (Basel); 2021 Oct; 8(11):. PubMed ID: 34821721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.
    Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D
    Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity.
    Martins KAO; Cooper CL; Stronsky SM; Norris SLW; Kwilas SA; Steffens JT; Benko JG; van Tongeren SA; Bavari S
    EBioMedicine; 2016 Jan; 3():67-78. PubMed ID: 26870818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
    Zuckermann FA; Martin S; Husmann RJ; Brandt J
    Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA Vaccine Nanoplatforms and Innate Immunity.
    Wei L; Dong C; Zhu W; Wang BZ
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate.
    Xu Y; Zhou Z; Brooks B; Ferguson T; Obliosca J; Huang J; Kaneko I; Iwanaga S; Yuda M; Tsuji Y; Zhang H; Luo CC; Jiang X; Kong XP; Tsuji M; Tison CK
    Front Immunol; 2022; 13():900080. PubMed ID: 36059505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical perspective on topical vaccination strategies.
    G Popova P; Chen SP; Liao S; Sadarangani M; Blakney AK
    Adv Drug Deliv Rev; 2024 May; 208():115292. PubMed ID: 38522725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances of vaccine adjuvants for infectious diseases.
    Lee S; Nguyen MT
    Immune Netw; 2015 Apr; 15(2):51-7. PubMed ID: 25922593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.